Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	IMRT 6 Weeks + Cisplatin	158
Overall Study	STARTED	IMRT 5 Weeks	150
Overall Study	Eligible	IMRT 6 Weeks + Cisplatin	157
Overall Study	Eligible	IMRT 5 Weeks	149
Overall Study	Started Study Treatment	IMRT 6 Weeks + Cisplatin	152
Overall Study	Started Study Treatment	IMRT 5 Weeks	147
Overall Study	Negative Post-treatment PET	IMRT 6 Weeks + Cisplatin	58
Overall Study	Negative Post-treatment PET	IMRT 5 Weeks	57
Overall Study	COMPLETED	IMRT 6 Weeks + Cisplatin	157
Overall Study	COMPLETED	IMRT 5 Weeks	149
Overall Study	NOT COMPLETED	IMRT 6 Weeks + Cisplatin	1
Overall Study	NOT COMPLETED	IMRT 5 Weeks	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02254278/flow